Source: GlobalData
US tariffs could accelerate supply chain diversification in medtech sector, says GlobalData
Posted in Medical Devices
The US Trade Representative’s (USTR) plan to reinstate Section 301 tariffs targets Class I and II medical devices, including orthopedic instruments frequently sourced from China. The move is expected to lead to a rise in cost pressures and supply chain risks in the medtech sector. As such, tariff pressures could accelerate supply chain diversification and regional manufacturing in the sector, according to GlobalData, a leading data and analytics company.
The tariffs, part of a revived Trump-era trade strategy, aim to counter China’s economic influence and encourage domestic manufacturing. However, medtech leaders warn the move could raise healthcare costs and limit patient access to essential technologies.
Zimmer Biomet has recently announced that proposed US tariffs on medical devices imported from China could reduce its 2025 profits by $60 million to $80 million. Zimmer Biomet’s update reflects the broader implications of geopolitical trade shifts on global healthcare. The global musculoskeletal healthcare company is evaluating mitigation strategies such as supplier diversification, logistics optimization, and potential reshoring.
Graysen Vigneux, Medical Analyst at GlobalData, commented: “The impact of these tariffs is significant for globally integrated firms like Zimmer Biomet. While intended to boost US production, the immediate effect may be higher costs that ripple through to providers and patients.”
Many of Zimmer Biomet’s orthopedic instruments, typically low-margin, high-volume products, fall under the tariff scope and cannot be easily transitioned to US manufacturing without major investment and regulatory delay.
Vigneux concludes: “The US medtech industry, already facing inflation, labor shortages, and stricter regulation, now confronts added financial and strategic uncertainty. Companies must remain agile to navigate shifting trade policy without compromising access or quality.”